[IMKASID 2027]
Plan Your Next Trip to Seoul!
Pre-Registration for IMKASID 2027 is Ongoing!
🏯 More about Seoul:
imkasid.org/registration/mor…
📅 Apr. 29–May 1, 2027
📍 Grand Walkerhill Seoul, Korea
⏰ Pre-Registration Deadline: March 15, 2027
#IMKASID2027 #KASID #Seoul #Conference
2026 장 건강의 날 '일취월장(腸)' 캠페인 환우 설문조사가 연장되었습니다.
해당 설문조사는 환자 중심의 치료 환경 및 제도 개선을 위한 근거 자료로 활용될 예정입니다. 많은 관심과 참여 부탁 드립니다.
✅설문조사 기한: ~ 2026년 11월 30일(월)까지
✅참여 방법: isas.panel.co.kr/ISAS50/OnAi…
[IMKASID 2027] 📢Call for Abstracts!
Abstract Submission is ongoing!
Share your latest research and insights with colleagues from around the world.
📅 Deadline: Dec. 20, 2026
🔗 Submit Your Abstract: imkasid.org/abstract/
#IMKASID2027 #IMKASID #KASID #CallForAbstracts
🤖 Made with AI
[IMKASID 2027] GO IMKASID 2027 is NOW OPEN!🚀
🌏 Calling all Asian doctors outside Korea! Enhance your clinical skills through advanced training in Korea.
📅 GO IMKASID: Apr. 22–28, 2027
⏰ Application Deadline: Jan. 21, 2027
🔗 imkasid.org/program/goimkasi…
#IMKASID2027 #GOIMKASID
🔥 IMKASID 2027 Call for Abstracts is NOW OPEN!
Share your latest research and join us for the 10th IMKASID in Seoul!
📝 Abstract Submission: Now Open
📅 April 29 – May 1, 2027
📍 Grand Walkerhill Seoul, Korea
🔗 Submit your abstract: imkasid.org
#IMKASID2027
✨ IMKASID 2027 Website is Now Live!
Check out abstract submission & pre-registration dates and join us for the 10th anniversary of IMKASID! 🎉
📅 Apr. 29–May 1, 2027
📍 Grand Walkerhill Seoul, Korea
🌐 imkasid.org
#IMKASID2027 #IMKASID #KASID
🤖 Made with AI
2026 장 건강의 날 캠페인 "일취월장(腸)"에 여러분을 초대합니다! 🥳
✅일시: 2026년 10월 31일(토) 14:00부터
✅장소: 서울 스페이스쉐어 중부센터 스카이홀
🚩참가신청: m.site.naver.com/2eddo
🚩설문조사 참여: isurvey.panel.co.kr/?Alias=3…
#염증성 장질환 #장날 캠페인 #KASID #대한장연구학회
theKASID retweeted
Long-term efficacy and safety of vedolizumab compared with infliximab in biologic-naive ulcerative colitis: a systematic review and meta-analysis
doi.org/10.5217/ir.2026.0010…
theKASID retweeted
Hot topic: Step- Up Therapy in Newly Diagnosed Crohn’s Disease: Real-World Trends from Japan
doi.org/10.5217/ir.2025.0005…
🤖 Made with AI
theKASID retweeted
Long-term clinical and endoscopic efficacy of vedolizumab and therapeutic persistence in patients with ulcerative colitis in China: a multicenter observational study
doi.org/10.5217/ir.2025.0004…




























